The American Association for the Study of Liver Diseases, the Canadian Association for the Study of the Liver, and the Mexican Association for the Study of the Liver are joining forces to lead a timely discussion on the impact of the varied public health responses to the COVID-19 pandemic on patients with liver disease. After providing an update on the burden of COVID-19 in general and on the liver patient population throughout North America, speakers and panelists from Canada, Mexico and the United States will discuss similarities and differences in terms of access to care in the three countries and address ways in which clinicians and researchers can address health care disparities in their own practices.
This webinar will:
- Review the burden of COVID-19 in general and within the hepatology patient population in Canada, Mexico, and the United States.
- Compare and contrast current public health measures, guidelines, and community response throughout North America.
- Describe the similarities and differences in access to care and related to health care disparities by region.
- Identify possible solutions to reduce regional health care disparities related to COVID-19 in patients with liver disease.
American Association for the Study of Liver Diseases (AASLD)
Canadian Association for the Study of the Liver (CASL)
Mexican Association of Hepatology (AMH)
AASLD COVID-19 Clinical Oversight Subcommittee
Kelly W. Burak, MD, FRCPC, MSc
University of Calgary
Laura E. Cisneros Garza, MD
Hospital San José Tec Salud, Monterrey N.L.
Jennifer C. Price, MD, PhD
University of California, San Francisco
Jordan J. Feld, MD, MPH, FAASLD
Toronto Western Hospital Liver Center
Ignacio Aiza, MD
Hospital Angeles Lomas